FDA Debars Liang
03/06/2013
Federal Register Notice: FDA is issuing an order under the FD&C Act permanently debarring Cheng Yi Liang, from providing services ...
Guidance on IDEs for Retinal Prostheses
03/06/2013
Federal Register Notice: FDA is making available a guidance: Investigational Device Exemption (IDE) Guidance for Retinal Prosthese...
Panel to Discuss Certain Assay Classifications
02/27/2013
Oncologic Panel to Discuss NDAs for Renal Cell and Ocular Melanomas
02/27/2013
Federal Register Notice: FDA’s Oncologic Drugs Advisory Committee will meet 5/2, from 8 a.m. to 5 p.m. at FDA’s White ...
FDA Changes Time, Agenda for Science Board Meeting
02/27/2013
Panel to Discuss Titan NDA for Opioid Dependence
02/27/2013
Panel to Discuss Bausch and Lomb’s Trulign Toric IOL
02/27/2013
Federal Register Notice: FDA’s Ophthalmic Devices Panel will meet 4/8, from 8:30 a.m. to 6 p.m. at the Hilton Washington, DC...
FDA Alliance Sounds Alarm on Funding to Science Board
02/27/2013
FDA’s mission is again at risk and its responsibilities grow each year because Congress enacts new laws, but funding doesn&r...
Guidance on Device Recalls, Enhancements
02/22/2013
Review Period Set for Edwards’ Sapien Heart Valve
02/22/2013
Federal Register Notice: FDA has determined the regulatory review period for Edwards Lifesciences’ Sapien Transcatheter Hear...
